Clinical Trial Details

Overview

Research Study Summary

A double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with acute mania associated with Bipolar I Disorder

Purpose

To evaluate the efficacy, safety, and tolerability of cariprazine monotherapy
versus placebo for the treatment of acute manic or mixed episodes associated
with bipolar I disorder. For safety reasons, patients will be asked to be
hospitalized during the screening phase and for a minimum of 2 weeks during
the treatment period.

Please contact Alexian Brothers for more information on participation.

Facility Type

Contact

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:

Address:

City:

State:

Zip/Postal Code:

Country:

Phone:

Email:

Message:

Please leave this field empty.

CW ID:
176868

Date Last Changed:
July 22, 2013

DISCLAIMER:CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.